Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Credit Suisse Falls as Swiss Probe Rolls On, Archegos Loss Hits

Published 04/22/2021, 10:33 AM
Updated 04/22/2021, 10:33 AM
© Reuters.

By Dhirendra Tripathi

Investing.com – Credit Suisse (NYSE:CS) was trading 3% lower Thursday as concerns mounted over what Finma’s probe would throw up as the Swiss regulator gets ready to initiate enforcement proceedings against Switzerland’s second largest commercial bank for any role in the collapse of Greensill Capital and Archegos.

Credit Suisse shares are down by a third from their 52-week high of $14.95.

The bank has suspended its share buyback and cut dividend. Investors were also not impressed by Credit Suisse raising $2 billion to bolster its capital.

Credit Suisse posted a loss of 757 million Swiss francs ($825 million) in the first quarter as the Archegos hit wiped out gains from a bumper trading business.

Thomas Gottstein, chief executive officer of Credit Suisse Group AG, minced no words in his statement: “The loss we report this quarter, because of this matter, is unacceptable”.

The total Archegos charge for the first quarter stands at 4.4 billion Swiss francs, the company said in a release.

It said another damage of 600 million Swiss francs on the same account was likely. The company has now exited 97% of the related positions with respect to Archegos.

 

 

 

 

 

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.